Pirkko Sulila Tamsen, PhD, CEO, was previously owner
and CEO of the clinical CRO SEDOC PM. Before leading SEDOC,
she worked in Research and Management positions in preclinical
and clinical research at Astra and Kabi-Pharmacia and has also
had a senior marketing and business development position in
A+Science.
Jan Sandström, Business Development and Licensing,
M.Sci Pharm. Previously Senior Management positions in Sales,
Marketing and Business Development at Astra/AstraZeneca, Orexo
and several other biotech companies.
Patric Stenberg, PhD, Chief Scientific Officer, previously
held the position of Senior Scientist at Wyeth, USA. Before
joining Wyeth he worked as a scientist at Pfizer, USA.
Sven Jacobsson, CMC, PhD, Adjunct Professor at Stockholm
University and owner of BioPharmaLinx, previously Senior Management
and Director positions at Kabi Pharmacia and AstraZeneca.
Johan Malm, PhD, IP and Medicinal Chemistry, Consultant
from Actar, previously Line and Project Manager at Karo Bio.
Before joining Karo Bio he worked at IDEON, Lund.
Kimmo Sinervo, Controller,Business Administration
and Economics at Universities of Uppsala and Stockholm. Previously
in small and middle-sized companies.
NovaSAID
AB • Fogdevreten 2 A • S-171 65 Solna • Sweden •
Reg 556669-2181 •
